- Directors and Auditors
- Articles of Association
- General Meetings
- - Previous General Meetings
- Insider Trading
Notice of Annual General Meeting of Dignitana AB (publ)
The shareholders in Dignitana AB (publ), 556730-5346, ("Company") is hereby summoned to the Annual General Meeting held on Wednesday of the 15 May 2019 at 9.00 at the Company's premises, Traktorgränden 3, in Lund, Sweden.
Right to attend the general meeting and notification
Shareholders who wish to participate in the Annual General Meeting (“AGM”) must be included in the share register maintained by Euroclear Sweden AB on Thursday May 9, 2019 and register to attend the meeting by email to firstname.lastname@example.org or by telephone +46-77-07 91 885 by no later than Thursday May 9 2019. The notification must state the full name of the shareholder, personal or corporate identity number, shareholding, address, daytime telephone number, and, where appropriate, the representative or number of assistants (not more than 2). The notification shall be accompanied, where appropriate, by proxies, powers of attorney, registration certificates and other documents of authorization.
Shareholders, whose shares are registered in the name of a bank or other nominee, must temporarily register their shares in their own name with Euroclear Sweden AB in order to be entitled to participate in the Annual General Meeting. Such registration, which normally is processed in a few days, must be completed no later than Thursday of the 9 May 2019 and must therefore be requested from the nominee well before this date.
The complete notice is available via the link here: https://dignitana.com/2019agm/
William Cronin, Chief Executive Officer, Dignitana AB email@example.com +1 469 917 5555
Mikael Wahlgren, Deputy Managing Director, Dignitana AB firstname.lastname@example.org +46 709 33 72 20
About Dignitana AB (publ)
Dignitana AB is the world leader in clinically superior scalp cooling technology. The company produces The DigniCap® Cooling System, a patented medical cooling device that offers cancer patients the ability to minimize hair loss during chemotherapy. FDA cleared since 2015, DigniCap provides continuous cooling with high efficacy, safety and acceptable patient comfort. Dignitana AB is listed on Nasdaq First North Stockholm in Sweden with headquarters in Lund, Sweden and operations based in Dallas, Texas in the United States. Company subsidiaries are Dignitana, Inc. in the United States and Dignitana S.r.l. in Italy. Erik Penser Bank is Certified Adviser. Learn more at www.dignitana.se and www.dignicap.com.